.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AE07_InsulinIcodec.InsulinIcodec .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AE07_InsulinIcodec.InsulinIcodec| name: | InsulinIcodec | |
| ATC code: | A10AE07 | route: | subcutaneous |
| compartments: | 2 | |
| dosage: | 420 | mg |
| volume of distribution: | 11 | L |
| clearance: | 0.03 | L/h |
| other parameters in model implementation | ||
Insulin icodec is a long-acting, once-weekly basal insulin analogue developed for the treatment of diabetes mellitus in adults. Its ultra-long action profile allows for stable and sustained glucose-lowering effects, providing an alternative to daily basal insulins. It is approved for medical use in the European Union.
Population pharmacokinetic parameters reported for adult subjects with type 2 diabetes mellitus, both male and female, following subcutaneous administration.